John Maraganore, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 67,744 shares at $198.02 ($13.5M) on 2021-08-13, disclosed to the SEC on 2021-08-16.
Open-market sale of $13.5M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $198.02 | 2,441 | $483K | 3.6% |
| 2 | $198.02 | 2,441 | $483K | 3.6% |
| 3 | $198.93 | 4,160 | $828K | 6.1% |
| 4 | $198.93 | 4,160 | $828K | 6.1% |
| 5 | $199.92 | 23,336 | $4.7M | 34.5% |
| 6 | $199.92 | 23,336 |
| $4.7M |
| 34.5% |
| 7 | $200.84 | 3,828 | $769K | 5.7% |
| 8 | $200.84 | 3,828 | $769K | 5.7% |
| 9 | $201.55 | 214 | $43K | 0.3% |
| Total | $199.77 avg | 67,744 | $13.5M | 100% |
| Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |
| ALNY | SELL | 2020-08-21 | $9.5M | — | Filing → |